EARLY AND SPECIFIC DIAGNOSIS OF SEROPOSITIVITY TO HIV BY AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY USING ENV-DERIVED SYNTHETIC PEPTIDES

被引:10
作者
FENOUILLET, E
SORENSEN, AM
LACROIX, M
COUTELLIER, A
HERSON, S
FRETZFOUCAULT, C
GLUCKMAN, JC
机构
[1] IAF BIOCHEM,MONTREAL,QUEBEC,CANADA
[2] GRP HOSP PITIE SALPETRIERE,CTR TRANSFUS SANGUINE,F-75651 PARIS 13,FRANCE
关键词
Enzyme-linked immunosorbent assay; HIV; Indeterminate Western blot; Seroconversion; Serology;
D O I
10.1097/00002030-199011000-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe and evaluate the sensitivity and specificity of an enzyme-linked immunosorbent assay (ELISA) using a 22-amino-acid peptide corresponding to the carboxy-terminal end of HIV-1 gp120 and two 30-amino-acid long cyclic peptides including the two vicinal cysteines present on HIV-1 gp41 and on HIV-2 gp36. This test was evaluated. Data obtained with the Western blot (WB) and the peptide-based ELISA on a first panel composed of sera from 547 patients attending a specialized outpatient clinic (high-risk population) are in perfect agreement; moreover, 39 samples that had falsely been found positive with a viral lysate-based ELISA were not detected by peptide-based ELISA. The second panel was composed of 309 sera which were difficult to resolve using both WB and viral lysate-based ELISA. Using the peptide-based ELISA, 134 were found clearly positive and 173 clearly negative; only two were falsely positive. Finally, sera from 16 individuals examined at the time of seroconversion gave high absorbancy readings even if they were weakly reactive by WB (weak gp160 band). This test is thus highly sensitive and specific, and capable of detecting early seroconversion. It is also instrumental in clearly defining samples that are found indeterminate in the WB, and consequently it avoids the unnecessary follow-up required when a false-positive result is obtained using viral lysate-based ELISA.
引用
收藏
页码:1137 / 1140
页数:4
相关论文
共 18 条
  • [1] BACKER U, 1988, AIDS, V2, P477, DOI 10.1097/00002030-198812000-00011
  • [2] BAHRAOUI E, 1990, BLOOD, V76, P251
  • [3] VIRUS ENVELOPE PROTEIN OF HTLV-III REPRESENTS MAJOR TARGET ANTIGEN FOR ANTIBODIES IN AIDS PATIENTS
    BARIN, F
    MCLANE, MF
    ALLAN, JS
    LEE, TH
    GROOPMAN, JE
    ESSEX, M
    [J]. SCIENCE, 1985, 228 (4703) : 1094 - 1096
  • [4] BLUCKMAN JC, 1989, AIDS, V3, P855
  • [5] EVALUATION OF COMMERCIAL ENZYME IMMUNOASSAYS FOR ANTI-HIV-1 USING EAST-AFRICAN SERA
    BREDBERGRADEN, U
    KIANGO, J
    MHALU, F
    BIBERFELD, G
    [J]. AIDS, 1988, 2 (04) : 281 - 285
  • [6] FELIX AM, 1980, INT J PEPT PROT RES, V15, P342
  • [7] ROLE OF N-LINKED GLYCANS IN THE INTERACTION BETWEEN THE ENVELOPE GLYCOPROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS AND ITS CD4 CELLULAR RECEPTOR - STRUCTURAL ENZYMATIC ANALYSIS
    FENOUILLET, E
    CLERGETRASLAIN, B
    GLUCKMAN, JC
    GUETARD, D
    MONTAGNIER, L
    BAHRAOUI, E
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (03) : 807 - 822
  • [8] GENESCA J, 1989, LANCET, V2, P171
  • [9] ABSENCE OF HIV INFECTION IN BLOOD-DONORS WITH INDETERMINATE WESTERN BLOT TESTS FOR ANTIBODY TO HIV-1
    JACKSON, JB
    MACDONALD, KL
    CADWELL, J
    SULLIVAN, C
    KLINE, WE
    HANSON, M
    SANNERUD, KJ
    STRAMER, SL
    FILDES, NJ
    KWOK, SY
    SNINSKY, JJ
    BOWMAN, RJ
    POLESKY, HF
    BALFOUR, HH
    OSTERHOLM, MT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (04) : 217 - 222
  • [10] LACROIX M, 1989, 5 INT C AIDS MONTR